Oral solid dosage forms (OSDFs), notably capsules and tablets, continue to be the most popular drug form used worldwide. Here are some common questions and insights from Deepak Thassu, VP of LGM Pharma’s R&D and Regulatory Division, about OSDF use and manufacturing. 1. Why do OSDFs dominate the global pharmaceutical market? Solid dosage forms may[…]
On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.
